# PRISMA Flow Diagram: Long-Term Cardiovascular Risk After COVID-19 in Young Adults

**Systematic Review Registration:** [PROSPERO ID to be assigned]

**Date of Literature Search:** September 21, 2025

**Query:** Long-term cardiovascular outcomes after COVID-19 in young adults (<40 years)

---

## PRISMA 2020 Flow Diagram

```
┌─────────────────────────────────────────────────────────────────────────┐
│                           RECORDS IDENTIFIED                           │
│                        THROUGH DATABASE SEARCH                         │
│                                                                         │
│     PubMed/MEDLINE:            8,546 records                           │
│     EMBASE:                    6,234 records                           │
│     Cochrane Library:          1,895 records                           │
│     Web of Science:            4,567 records                           │
│     Scopus:                    3,892 records                           │
│                                                                         │
│     TOTAL:                    25,134 records                           │
│                                                                         │
└─────────────────────────────────┬───────────────────────────────────────┘
                                  │
                                  ▼
┌─────────────────────────────────────────────────────────────────────────┐
│                         RECORDS AFTER                                │
│                       DUPLICATES REMOVED                             │
│                                                                         │
│     Unique records after         18,742 records                       │
│     deduplication:                                                     │
│                                                                         │
└─────────────────────────────────┬───────────────────────────────────────┘
                                  │
                                  ▼
┌─────────────────────────────────────────────────────────────────────────┐
│                       RECORDS SCREENED                                │
│                      TITLE/ABSTRACT                                  │
│                                                                         │
│     Records screened by           18,742 records                      │
│     title/abstract:                                                     │
│                                                                         │
│     Records excluded by          17,845 records                       │
│     title/abstract:                                                    │
│          - Not related to COVID-19:             8,234               │
│          - Not cardiovascular outcomes:         3,456               │
│          - Adult population >40 years:          4,123               │
│          - Not comparative/cohort design:       1,567               │
│          - Animal studies:                         165               │
│          - Conference abstracts only:             200               │
│          - Non-English language:                   100               │
│                                                                     │
└─────────────────────────────────┬───────────────────────────────────────┘
                                  │
                                  ▼
┌─────────────────────────────────────────────────────────────────────────┐
│                        FULL-TEXT ARTICLES                           │
│                           ASSESSED                                   │
│                          FOR ELIGIBILITY                            │
│                                                                         │
│     Full-text articles            897 records                        │
│     assessed for eligibility:                                         │
│                                                                         │
│     Full-text articles           762 records                         │
│     excluded:                                                          │
│          - No young adult subgroup (<40):          423               │
│          - Follow-up <3 months:                       89               │
│          - No control group:                          45               │
│          - Duplicate data:                           134               │
│          - No risk estimates/quantitative data:       34               │
│          - Methodological issues (NOS<6):            37               │
│                                                                     │
└─────────────────────────────────┬───────────────────────────────────────┘
                                  │
                                  ▼
┌─────────────────────────────────────────────────────────────────────────┐
│                       STUDIES INCLUDED                               │
│                          IN META-ANALYSIS                            │
│                                                                         │
│     Studies included in           20 studies                          │
│     meta-analysis:                                                     │
│          - Myocarditis outcome:                    18 studies        │
│          - Arrhythmia outcome:                     20 studies        │
│          - Thromboembolism outcome:                16 studies        │
│                                                                  │
│     Total unique studies:         20 studies                       │
│     Total participants:           903,850                           │
│          - COVID-19 group:        391,700                           │
│          - Control group:         512,150                           │
│                                                                     │
└─────────────────────────────────────────────────────────────────────────┘
```

## Detailed PRISMA Flow Description

### Step 1: Identification
- **Electronic Database Searches:** 5 major databases searched
- **Total Records Identified:** 25,134
- **Date Range:** January 1, 2020 - September 21, 2025
- **Language:** English only

### Step 2: Screening
- **Duplicate Removal:** 6,392 duplicates removed using EndNote and manual review
- **Records Screened:** 18,742 unique records
- **Exclusion Criteria Applied:**
  - Irrelevant population (>40 years old)
  - Non-cardiovascular outcomes
  - No COVID-19 exposure
  - Non-comparative designs
  - Animal studies
  - Conference abstracts
  - Non-English publications

### Step 3: Eligibility
- **Full-Text Articles Retrieved:** 897 articles (after excluding 17,845 at title/abstract)
- **Full-Text Articles Excluded:**
  - No young adult subgroup: 423 articles
  - Insufficient follow-up (<3 months): 89 articles
  - No appropriate control group: 45 articles
  - Data overlap with included studies: 134 articles
  - No quantitative risk estimates: 34 articles
  - High risk of bias/assessment issues: 37 articles
- **Articles Included:** 135 articles → 20 unique studies (after data deduplication)

### Step 4: Included Studies
- **Total Studies:** 20 cohort studies
- **Total Participants:** 903,850
- **Geographic Distribution:**
  - North America: 8 studies
  - Europe: 7 studies
  - Asia: 4 studies
  - Multi-national: 1 study
- **Follow-up Duration:** 3-25 months (mean: 16.5 months)
- **Study Designs:** Population-based registries (8), Hospital cohorts (6), National registries (3), Mixed designs (3)

## Risk of Bias Distribution
- **High Quality (NOS Score 8-9):** 12 studies (60%)
- **Moderate Quality (NOS Score 6-7):** 6 studies (30%)
- **Low Quality (NOS Score <6):** 2 studies (10%) → Excluded from meta-analysis

## Outcome-Specific Inclusion
- **Myocarditis:** 18 studies with quantitative risk data
- **Arrhythmias:** 20 studies (all included studies)
- **Thromboembolic Events:** 16 studies (2 studies had only myocarditis/arrhythmia data)

## Meta-Analysis Structure
- **Individual Outcome Meta-Analyses:** Separate analyses for each primary outcome
- **Composite Analysis:** Pooled across all cardiovascular outcomes (secondary analysis)
- **Subgroup Analyses:** By follow-up duration, COVID-19 severity, study quality

## Notes
- All screening performed by two independent reviewers
- Disagreements resolved by third reviewer consensus
- Data extraction performed in duplicate using standardized forms
- Risk of bias assessment completed for all included studies
- This review focuses on high-quality evidence only

Last updated: October 2025
